The incidence of colorectal cancers detected at an early stage, that is stage T2 or less, has increased over the last decade, driven primarily by better access to screening and diagnostic pathways. Consequently, timely treatment leads to better outcomes. Early stage rectal cancers (ERC), by virtue of their location, allows for alternative treatment strategies towards organ (rectum) preservation. Local excision techniques have evolved and improved with advances in radiological assessment and minimally invasive surgery. However, decisions on treatment to mitigate local recurrence remain a challenge. This chapter explores the current understanding of the management of ERC and offers insights to the multidisciplinary team to aid treatment strategies.
Part of the book: Recent Understanding of Colorectal Cancer Treatment